Treatment subgroups according to treatment intent, treatment response rates, PFS and OS. (A) Pola-BR treatment subgroups according to treatment intent. (B) Response rates to Pola-BR. (C) PFS and OS. (i) PFS and (ii) OS for all patients. (iii) PFS for patients in the stand-alone Pola-BR cohort (no planned SCT or CAR T-cell therapy) according to treatment response. CI, confidence interval; HR, hazard ratio; PR, partial response. (iv) OS for patients in the stand-alone Pola-BR cohort (no planned SCT or CAR T-cell therapy) according to treatment response.